Association of remnant cholesterol with kidney outcomes in adults with type 2 diabetes: a systematic review and meta-analysis.

Authors

Jie Gao, Jiaqi Wang, Zhangli Wang

Published in

Frontiers in endocrinology. Volume 17. Pages 1969361. Epub Oct 16, 2026.

Abstract

Remnant cholesterol (RC) reflects the cholesterol carried by triglyceride-rich lipoprotein remnants and may capture lipid-related kidney risk not fully represented by conventional lipid measures. We evaluated the associations between RC and kidney outcomes in adults with type 2 diabetes mellitus (T2DM).
Following PRISMA 2020, PubMed/MEDLINE, Scopus, the Cochrane Library, Google Scholar, Wiley Online Library, and ScienceDirect were searched for longitudinal and cross-sectional observational studies evaluating circulating RC and kidney outcomes in adults with T2DM. Studies of mixed populations were eligible only when T2DM-specific data could be extracted. Adjusted effect estimates were pooled separately by study design and kidney outcome using restricted maximum likelihood random-effects models with Hartung-Knapp adjustment.
Seventeen articles contributed 18 independent estimates from 2,817,820 participants with T2DM. The exploratory all-study model showed an association between higher RC and adverse kidney outcomes (association ratio 1.50, 95% CI 1.32-1.72, P < 0.001; I² = 87.6%). The longitudinal model, comprising 12 independent estimates from 11 articles, showed a similar association (HR 1.27, 95% CI 1.17-1.37, P < 0.001; I² = 42.9%). Outcome-specific analyses showed an association with incident diabetic kidney disease (DKD; HR 1.27, 95% CI 1.15-1.41, P = 0.0029). The estimate for kidney failure/end-stage kidney disease was positive but not statistically significant (HR 1.56, 95% CI 0.82-2.97, P = 0.115). The association with DKD progression also did not reach statistical significance (HR 1.17, 95% CI 1.00-1.37, P = 0.052), while one study reported an association with incident albuminuria (HR 1.23, 95% CI 1.06-1.43, P = 0.007). Six cross-sectional studies showed an association between higher RC and prevalent or early DKD in adults with T2DM (OR 2.03, 95% CI 1.71-2.42, P < 0.001; I² = 2.5%). The longitudinal association remained after restricting the analysis to estimates adjusted for blood pressure, glycemia, and adiposity (HR 1.28, 95% CI 1.21-1.37, P < 0.001). A smaller subset that included continuous estimates showed that a 0.1 mmol/L increase in RC was not associated with incident DKD (HR 1.02, 95% CI 0.98-1.07, P = 0.197).
Higher RC was associated with incident and prevalent DKD and with adverse longitudinal kidney outcomes overall in adults with T2DM. RC may serve as a complementary kidney-risk marker, but the observational evidence does not establish causality or a clinical threshold.Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420261475085, identifier CRD420261475085.

PMID:
42964092
Bibliographic data and abstract were imported from PubMed on 31 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.